
Share on:
Joint replacement is the largest segment in orthopedics, accounting for $19 billion in revenue or 35% of the global market. Its size combined with its adoption of enabling and digital technologies makes joint replacement an attractive space for portfolio expansions, partnerships and acquisitions. Our latest market dive highlights the current and projected size of the segment; the top 10 companies in knee, hip and extremities by revenue; and key trends and executive insights.

RELATED ARTICLES
Sandvik to Divest Additive Manufacturing Business Unit
Jun 16 2026 , Julie A. Vetalice
Cretex Medical Acquires Select Assets and Capabilities of Holland Molds
Jun 16 2026 , Julie A. Vetalice
Medical Component Specialists Appoints President & CEO
Jun 15 2026 , Julie A. Vetalice



